F 18-FDG heart uptake in oncologic pet studies

González Espinoza, Patricio; Massardo Vega, Teresa; Alavi, Abass.
Rev. med. nucl. Alasbimn j ; 3(11)abr. 2001. ilus, graf
Artículo en Inglés | LILACS | ID: lil-284732

Documentos relacionados

  1. Preclinical study and first-in-human imaging of [<sup>18</sup>F]FAP-2286, and comparison with 2-[<sup>18</sup>F]FDG PET/CT in various cancer patients.
  2. Review of clinical practice utility of positron emission tomography with 18F-fluorodeoxyglucose in assessing tumour response to therapy.
  3. Changes of [<sup>18</sup>F]FDG-PET/CT quantitative parameters in tumor lesions by the Bayesian penalized-likelihood PET reconstruction algorithm and its influencing factors.
  4. Comparison of three ¹8F-labeled carboxylic acids with ¹8F-FDG of the differentiation tumor from inflammation in model mice.
  5. [Examination of SUV of regional activity concentration for simultaneous emission/transmission acquisition using the mask technique].
  6. Musculoskeletal pitfalls in 18F-FDG PET/CT: pictorial review.
  7. Chemistry Considerations for the Clinical Translation of Oncology PET Radiopharmaceuticals.
  8. Effect of blood glucose level on standardized uptake value (SUV) in <sup>18</sup>F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements.
  9. Role of Optimal Quantification of FDG PET Imaging in the Clinical Practice of Radiology.
  10. Anatomolecular imaging with 2-deoxy-2-[18F]fluoro-D-glucose: bench to outpatient center.